Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04509401Completed
Randomised, double-blind trial (2 arms), sponsored by Bangabandhu Sheikh Mujib Medical University. Primary endpoint: Urinary homovanillic acid Concentration at 12 weeks. Started Jan 2020; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04509401.